Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 320

1.

Novel Silicon Titanium Diboride Micropatterned Substrates for Cellular Patterning.

Friguglietti J, Das S, Le P, Fraga D, Quintela M, Gazze SA, McPhail D, Gu J, Sabek O, Gaber AO, Francis LW, Zagozdzon-Wosik W, Merchant FA.

Biomaterials. 2020 Mar 5;244:119927. doi: 10.1016/j.biomaterials.2020.119927. [Epub ahead of print]

PMID:
32199283
2.

Assessment of infectious complications in elderly kidney transplant recipients receiving induction with anti-thymocyte globulin vs basiliximab.

Pham C, Kuten SA, Knight RJ, Nguyen DT, Graviss EA, Gaber AO.

Transpl Infect Dis. 2020 Feb 7:e13257. doi: 10.1111/tid.13257. [Epub ahead of print]

PMID:
32031729
3.

Serum C-peptide and osteocalcin levels in children with recently diagnosed diabetes.

Sabek OM, Redondo MJ, Nguyen DT, Beamish CA, Fraga DW, Hampe CS, Mulukutla SN, Graviss EA, Gaber AO.

Endocrinol Diabetes Metab. 2019 Nov 29;3(1):e00104. doi: 10.1002/edm2.104. eCollection 2020 Jan.

4.

Delayed Implantation of Pumped Kidneys Decreases Renal Allograft Futility in Combined Liver-Kidney Transplantation.

Lunsford KE, Agopian VG, Yi SG, Nguyen DTM, Graviss EA, Harlander-Locke MP, Saharia A, Kaldas FM, Mobley CM, Zarrinpar A, Hobeika M, Veale JL, Podder H, Farmer DG, Knight RJ, Danovitch GM, Gritsch HA, Li XC, Ghobrial RM, Busuttil RW, Gaber AO.

Transplantation. 2019 Oct 23. doi: 10.1097/TP.0000000000003040. [Epub ahead of print]

PMID:
31651787
5.

Weight Gain After Simultaneous Kidney and Pancreas Transplantation.

Knight RJ, Islam AK, Pham C, Graviss EA, Nguyen DT, Moore LW, Kagan A, Sadhu AR, Podder H, Gaber AO.

Transplantation. 2020 Mar;104(3):632-639. doi: 10.1097/TP.0000000000002862.

PMID:
31335775
6.

Corrections to: Checkpoint inhibitor therapy for cancer in solid organ transplantation recipients: an institutional experience and a systematic review of the literature.

Abdel-Wahab N, Safa H, Abudayyeh A, Johnson DH, Trinh VA, Zobniw CM, Lin H, Wong MK, Abdelrahim M, Gaber AO, Suarez-Almazor ME, Diab A.

J Immunother Cancer. 2019 Jun 24;7(1):158. doi: 10.1186/s40425-019-0639-4.

7.

Outcomes of Liver Transplantation for Hepatocellular Carcinoma Beyond the University of California San Francisco Criteria: A Single-center Experience.

Victor DW 3rd, Monsour HP Jr, Boktour M, Lunsford K, Balogh J, Graviss EA, Nguyen DT, McFadden R, Divatia MK, Heyne K, Ankoma-Sey V, Egwim C, Galati J, Duchini A, Saharia A, Mobley C, Gaber AO, Ghobrial RM.

Transplantation. 2020 Jan;104(1):113-121. doi: 10.1097/TP.0000000000002835.

PMID:
31233480
8.

The Houston Methodist Lung Transplant Risk Model: A Validated Tool for Pretransplant Risk Assessment.

Chan EY, Nguyen DT, Kaleekal TS, Goodarzi A, Graviss EA, Gaber AO; Houston Methodist Lung Outcomes Group.

Ann Thorac Surg. 2019 Oct;108(4):1094-1100. doi: 10.1016/j.athoracsur.2019.03.108. Epub 2019 May 10.

PMID:
31082356
9.

Checkpoint inhibitor therapy for cancer in solid organ transplantation recipients: an institutional experience and a systematic review of the literature.

Abdel-Wahab N, Safa H, Abudayyeh A, Johnson DH, Trinh VA, Zobniw CM, Lin H, Wong MK, Abdelrahim M, Gaber AO, Suarez-Almazor ME, Diab A.

J Immunother Cancer. 2019 Apr 16;7(1):106. doi: 10.1186/s40425-019-0585-1. Erratum in: J Immunother Cancer. 2019 Jun 24;7(1):158.

10.

Successful Kidney Transplantation Is Associated With Weight Gain From Truncal Obesity and Insulin Resistance.

Workeneh B, Moore LW, Nolte Fong JV, Shypailo R, Gaber AO, Mitch WE.

J Ren Nutr. 2019 Nov;29(6):548-555. doi: 10.1053/j.jrn.2019.01.009. Epub 2019 Mar 7.

PMID:
30852120
11.

Disparate outcomes observed within Kidney Disease: Improving Global Outcomes (KDIGO) acute kidney injury stage 1.

Sparrow HG, Swan JT, Moore LW, Gaber AO, Suki WN.

Kidney Int. 2019 Apr;95(4):905-913. doi: 10.1016/j.kint.2018.11.030. Epub 2019 Feb 26.

PMID:
30819553
12.

Ciprofloxacin for BK viremia prophylaxis in kidney transplant recipients: Results of a prospective, double-blind, randomized, placebo-controlled trial.

Patel SJ, Knight RJ, Kuten SA, Graviss EA, Nguyen DT, Moore LW, Musick WL, Gaber AO.

Am J Transplant. 2019 Jun;19(6):1831-1837. doi: 10.1111/ajt.15328. Epub 2019 Apr 4.

PMID:
30811872
13.

Cross-sectional evaluation of the relationship between vitamin D status and supplement use across levels of kidney function in adults.

Moore LW, Suki WN, Lunsford KE, Sabek OM, Knight RJ, Gaber AO.

BMJ Open. 2019 Feb 22;9(2):e022471. doi: 10.1136/bmjopen-2018-022471.

14.

Transplantation for Hepatocellular Carcinoma: Is There a Tumor Size Limit?

Daoud A, Teeter L, Ghobrial RM, Graviss EA, Mogawer S, Sholkamy A, El-Shazli M, Gaber AO.

Transplant Proc. 2018 Dec;50(10):3577-3581. doi: 10.1016/j.transproceed.2018.04.038. Epub 2018 Apr 18.

PMID:
30577241
15.

Suitability of Estimated Glomerular Filtration Rate for Live Kidney Donor Selection.

Akhimiona CO, Nguyen DT, Graviss EA, Gaber AO, Suki WN.

Transplant Proc. 2018 Dec;50(10):3071-3075. doi: 10.1016/j.transproceed.2018.09.013. Epub 2018 Sep 8.

PMID:
30577168
16.

The importance of drug safety and tolerability in the development of new immunosuppressive therapy for transplant recipients: The Transplant Therapeutics Consortium's position statement.

Stegall MD, Troy Somerville K, Everly MJ, Mannon RB, Gaber AO, First MR, Agashivala N, Perez V, Newell KA, Morris RE, Sudan D, Romero K, Eremenco S, Mattera M, Spear N, Porter AC, O'Doherty I.

Am J Transplant. 2019 Mar;19(3):625-632. doi: 10.1111/ajt.15214. Epub 2019 Jan 23.

17.

Variability in endocrine cell identity in patients with chronic pancreatitis undergoing islet autotransplantation.

Beamish CA, Gaber AO, Afshar SF, Fraga DW, Hamilton DJ, Sabek OM.

Am J Transplant. 2019 May;19(5):1568-1576. doi: 10.1111/ajt.15154. Epub 2018 Nov 28.

PMID:
30372580
18.

Liver transplantation for locally advanced intrahepatic cholangiocarcinoma - Authors' reply.

Lunsford KE, Javle M, Gaber AO, Vauthey JN, Ghobrial RM.

Lancet Gastroenterol Hepatol. 2018 Aug;3(8):529-530. doi: 10.1016/S2468-1253(18)30167-5. No abstract available.

PMID:
30047444
19.

Short- and midterm results for internal jugular vein extension for short right renal vein kidney transplant.

Lu T, Yi SG, Bismuth J, Knight RJ, Gaber AO, Bechara CF.

Clin Transplant. 2018 Aug;32(8):e13312. doi: 10.1111/ctr.13312. Epub 2018 Jun 29.

PMID:
29888810
20.

Transcutaneously refillable, 3D-printed biopolymeric encapsulation system for the transplantation of endocrine cells.

Farina M, Chua CYX, Ballerini A, Thekkedath U, Alexander JF, Rhudy JR, Torchio G, Fraga D, Pathak RR, Villanueva M, Shin CS, Niles JA, Sesana R, Demarchi D, Sikora AG, Acharya GS, Gaber AO, Nichols JE, Grattoni A.

Biomaterials. 2018 Sep;177:125-138. doi: 10.1016/j.biomaterials.2018.05.047. Epub 2018 May 30.

PMID:
29886385
21.

Conversion from tacrolimus-mycophenolate mofetil to tacrolimus-mTOR immunosuppression after kidney-pancreas transplantation reduces the incidence of both BK and CMV viremia.

Knight RJ, Graviss EA, Nguyen DT, Kuten SA, Patel SJ, Gaber L, Gaber AO.

Clin Transplant. 2018 Jun;32(6):e13265. doi: 10.1111/ctr.13265. Epub 2018 May 12.

PMID:
29676018
22.

Liver transplantation for locally advanced intrahepatic cholangiocarcinoma treated with neoadjuvant therapy: a prospective case-series.

Lunsford KE, Javle M, Heyne K, Shroff RT, Abdel-Wahab R, Gupta N, Mobley CM, Saharia A, Victor DW, Nguyen DT, Graviss EA, Kaseb AO, McFadden RS, Aloia TA, Conrad C, Li XC, Monsour HP, Gaber AO, Vauthey JN, Ghobrial RM; Methodist–MD Anderson Joint Cholangiocarcinoma Collaborative Committee (MMAJCCC).

Lancet Gastroenterol Hepatol. 2018 May;3(5):337-348. doi: 10.1016/S2468-1253(18)30045-1. Epub 2018 Mar 13. Erratum in: Lancet Gastroenterol Hepatol. 2018 Jun;3(6):e3.

PMID:
29548617
23.

Treatment of Refractory Gastrointestinal Bleeding in Patients With Portal Hypertension: A Case Series and Treatment Algorithm.

Balogh J, Gordon-Burroughs S, Schwarz P, Galati J, McFadden RA, Cusick M, Snyder MJ, Bailey HR, Weiner M, Wong A, Ochoa RA, Saharia A, Gaber AO, Ghobrial RM.

Transplant Proc. 2017 Oct;49(8):1864-1869. doi: 10.1016/j.transproceed.2017.06.022.

PMID:
28923638
24.

Induction of IAPP amyloid deposition and associated diabetic abnormalities by a prion-like mechanism.

Mukherjee A, Morales-Scheihing D, Salvadores N, Moreno-Gonzalez I, Gonzalez C, Taylor-Presse K, Mendez N, Shahnawaz M, Gaber AO, Sabek OM, Fraga DW, Soto C.

J Exp Med. 2017 Sep 4;214(9):2591-2610. doi: 10.1084/jem.20161134. Epub 2017 Aug 1.

25.

Belatacept conversion in an HIV-positive kidney transplant recipient following anti-thymocyte globulin induction.

Kuten SA, Patel SJ, Baru A, Gaber AO, Crutchley RD, Ramanathan V, Knight RJ.

Transpl Infect Dis. 2017 Oct;19(5). doi: 10.1111/tid.12748. Epub 2017 Sep 11.

PMID:
28708266
26.

Optimal cut points of plasma and urine neutrophil gelatinase-associated lipocalin for the prediction of acute kidney injury among critically ill adults: retrospective determination and clinical validation of a prospective multicentre study.

Tecson KM, Erhardtsen E, Eriksen PM, Gaber AO, Germain M, Golestaneh L, Lavoria MLA, Moore LW, McCullough PA.

BMJ Open. 2017 Jul 10;7(7):e016028. doi: 10.1136/bmjopen-2017-016028.

27.

The detrimental impact of persistent vs an isolated occurrence of de novo donor-specific antibodies on intermediate-term renal transplant outcomes.

Loucks-DeVos JM, Eagar TN, Gaber AO, Patel SJ, Teeter LD, Graviss EA, Knight RJ.

Clin Transplant. 2017 Aug;31(8). doi: 10.1111/ctr.13025. Epub 2017 Jul 4.

PMID:
28582797
28.

Evaluation of Carotid Ultrasonography Screening Among Kidney Transplant Candidates: A Single-Center, Retrospective Study.

Rossitter CW, Vigo RB, Gaber AO, Swan JT, Suki WN.

Transplant Direct. 2017 Feb 9;3(3):e135. doi: 10.1097/TXD.0000000000000649. eCollection 2017 Mar.

29.

Frontiers in Organ Failure and Transplant Management.

Estep JD, Gaber AO.

Methodist Debakey Cardiovasc J. 2016 Oct-Dec;12(4 Suppl):1. doi: 10.14797/mdcj-12-4s1-1. No abstract available.

30.

Serum undercarboxylated osteocalcin correlates with hemoglobin A1c in children with recently diagnosed pediatric diabetes.

Redondo MJ, Shirkey BA, Fraga DW, Gaber AO, Sabek OM.

Pediatr Diabetes. 2017 Dec;18(8):869-873. doi: 10.1111/pedi.12501. Epub 2017 Jan 17.

PMID:
28093839
31.

Poor immune reconstitution is associated with symptomatic BK polyomavirus viruria in allogeneic stem cell transplant recipients.

Abudayyeh A, Hamdi A, Abdelrahim M, Lin H, Page VD, Rondon G, Andersson BS, Afrough A, Martinez CS, Tarrand JJ, Kontoyiannis DP, Marin D, Gaber AO, Oran B, Chemaly RF, Ahmed S, Abudayyeh I, Olson A, Jones R, Popat U, Champlin RE, Shpall EJ, Rezvani K.

Transpl Infect Dis. 2017 Feb;19(1). doi: 10.1111/tid.12632. Epub 2016 Dec 28.

PMID:
27862740
32.

Intermediate-Term Outcomes of Dual Adult versus Single-Kidney Transplantation: Evolution of a Surgical Technique.

Islam AK, Knight RJ, Mayer WA, Hollander AB, Patel S, Teeter LD, Graviss EA, Saharia A, Podder H, Asham EH, Gaber AO.

J Transplant. 2016;2016:2586761. doi: 10.1155/2016/2586761. Epub 2016 Jul 10.

33.

Sustained zero-order delivery of GC-1 from a nanochannel membrane device alleviates metabolic syndrome.

Filgueira CS, Nicolov E, Hood RL, Ballerini A, Garcia-Huidobro J, Lin JZ, Fraga D, Webb P, Sabek OM, Gaber AO, Phillips KJ, Grattoni A.

Int J Obes (Lond). 2016 Nov;40(11):1776-1783. doi: 10.1038/ijo.2016.129. Epub 2016 Jul 27.

PMID:
27460601
34.

Simultaneous Scalp, Skull, Kidney, and Pancreas Transplant from a Single Donor.

Selber JC, Chang EI, Clemens MW, Gaber L, Hanasono MM, Klebuc M, Skoracki RJ, Trask T, Yu P, Gaber AO.

Plast Reconstr Surg. 2016 Jun;137(6):1851-61. doi: 10.1097/PRS.0000000000002153.

PMID:
27219240
35.

Disparate rates of acute rejection and donor-specific antibodies among high-immunologic risk renal transplant subgroups receiving antithymocyte globulin induction.

Patel SJ, Suki WN, Loucks-DeVos J, Graviss EA, Nguyen DT, Knight RJ, Kuten SA, Moore LW, Teeter LD, Gaber LW, Gaber AO.

Transpl Int. 2016 Aug;29(8):897-908. doi: 10.1111/tri.12791. Epub 2016 Jul 7.

36.

Three-dimensional printed polymeric system to encapsulate human mesenchymal stem cells differentiated into islet-like insulin-producing aggregates for diabetes treatment.

Sabek OM, Farina M, Fraga DW, Afshar S, Ballerini A, Filgueira CS, Thekkedath UR, Grattoni A, Gaber AO.

J Tissue Eng. 2016 Apr 21;7:2041731416638198. doi: 10.1177/2041731416638198. eCollection 2016 Jan-Dec.

37.

Combination Drug Products for HIV-A Word of Caution for the Transplant Clinician.

Patel SJ, Kuten SA, Musick WL, Gaber AO, Monsour HP, Knight RJ.

Am J Transplant. 2016 Aug;16(8):2479-82. doi: 10.1111/ajt.13826. Epub 2016 May 23.

38.

Terminal Complement Inhibitor Eculizumab in Adult Patients With Atypical Hemolytic Uremic Syndrome: A Single-Arm, Open-Label Trial.

Fakhouri F, Hourmant M, Campistol JM, Cataland SR, Espinosa M, Gaber AO, Menne J, Minetti EE, Provôt F, Rondeau E, Ruggenenti P, Weekers LE, Ogawa M, Bedrosian CL, Legendre CM.

Am J Kidney Dis. 2016 Jul;68(1):84-93. doi: 10.1053/j.ajkd.2015.12.034. Epub 2016 Mar 21.

39.

Survival Benefit with Kidney Transplants from HLA-Incompatible Live Donors.

Orandi BJ, Luo X, Massie AB, Garonzik-Wang JM, Lonze BE, Ahmed R, Van Arendonk KJ, Stegall MD, Jordan SC, Oberholzer J, Dunn TB, Ratner LE, Kapur S, Pelletier RP, Roberts JP, Melcher ML, Singh P, Sudan DL, Posner MP, El-Amm JM, Shapiro R, Cooper M, Lipkowitz GS, Rees MA, Marsh CL, Sankari BR, Gerber DA, Nelson PW, Wellen J, Bozorgzadeh A, Gaber AO, Montgomery RA, Segev DL.

N Engl J Med. 2016 Mar 10;374(10):940-50. doi: 10.1056/NEJMoa1508380.

40.

Incidence and Factors Associated with De Novo DSA After BK Viremia in Renal Transplant Recipients.

Patel SJ, Kuten SA, Knight RJ, Graviss EA, Nguyen D, Gaber AO.

Clin Transpl. 2016;32:103-109.

PMID:
28564527
41.

Symptomatic BK Virus Infection Is Associated With Kidney Function Decline and Poor Overall Survival in Allogeneic Hematopoietic Stem Cell Recipients.

Abudayyeh A, Hamdi A, Lin H, Abdelrahim M, Rondon G, Andersson BS, Afrough A, Martinez CS, Tarrand JJ, Kontoyiannis DP, Marin D, Gaber AO, Salahudeen A, Oran B, Chemaly RF, Olson A, Jones R, Popat U, Champlin RE, Shpall EJ, Winkelmayer WC, Rezvani K.

Am J Transplant. 2016 May;16(5):1492-502. doi: 10.1111/ajt.13635. Epub 2016 Mar 2.

42.

Efficacy and cost-effectiveness of voriconazole prophylaxis for prevention of invasive aspergillosis in high-risk liver transplant recipients.

Balogh J, Gordon Burroughs S, Boktour M, Patel S, Saharia A, Ochoa RA, McFadden R, Victor DW, Ankoma-Sey V, Galati J, Monsour HP Jr, Fainstein V, Li XC, Grimes KA, Gaber AO, Aloia T, Ghobrial RM.

Liver Transpl. 2016 Feb;22(2):163-70. doi: 10.1002/lt.24365. Epub 2016 Jan 8.

43.

Osteocalcin Effect on Human β-Cells Mass and Function.

Sabek OM, Nishimoto SK, Fraga D, Tejpal N, Ricordi C, Gaber AO.

Endocrinology. 2015 Sep;156(9):3137-46. doi: 10.1210/EN.2015-1143. Epub 2015 Jul 7.

PMID:
26151356
44.

Association of dietary phosphate and serum phosphorus concentration by levels of kidney function.

Moore LW, Nolte JV, Gaber AO, Suki WN.

Am J Clin Nutr. 2015 Aug;102(2):444-53. doi: 10.3945/ajcn.114.102715. Epub 2015 Jun 3.

PMID:
26040641
45.

New-Onset Diabetes After Transplantation: Results From a Double-Blind Early Corticosteroid Withdrawal Trial.

Pirsch JD, Henning AK, First MR, Fitzsimmons W, Gaber AO, Reisfield R, Shihab F, Woodle ES.

Am J Transplant. 2015 Jul;15(7):1982-90. doi: 10.1111/ajt.13247. Epub 2015 Apr 16.

46.

Observations on the use of cidofovir for BK virus infection in renal transplantation.

Kuten SA, Patel SJ, Knight RJ, Gaber LW, DeVos JM, Gaber AO.

Transpl Infect Dis. 2014 Dec;16(6):975-83. doi: 10.1111/tid.12313. Epub 2014 Nov 21.

PMID:
25412701
47.

Osteocalcin protects against nonalcoholic steatohepatitis in a mouse model of metabolic syndrome.

Gupte AA, Sabek OM, Fraga D, Minze LJ, Nishimoto SK, Liu JZ, Afshar S, Gaber L, Lyon CJ, Gaber AO, Hsueh WA.

Endocrinology. 2014 Dec;155(12):4697-705. doi: 10.1210/en.2014-1430. Epub 2014 Oct 3.

48.

Liver transplantation in an adult with adenomatosis and congenital absence of the portal vein: a case report.

Gordon-Burroughs S, Balogh J, Weiner MA, Monsour HP Jr, Schwartz MR, Gaber AO, Ghobrial RM.

Transplant Proc. 2014 Sep;46(7):2418-21. doi: 10.1016/j.transproceed.2014.04.012.

PMID:
25242797
49.

Barriers to preemptive renal transplantation: a single center questionnaire study.

Knight RJ, Teeter LD, Graviss EA, Patel SJ, DeVos JM, Moore LW, Gaber AO.

Transplantation. 2015 Mar;99(3):576-9. doi: 10.1097/TP.0000000000000357.

PMID:
25083616
50.

Resolution of Mild Ganciclovir-Resistant Cytomegalovirus Disease with Reduced-Dose Cidofovir and CMV-Hyperimmune Globulin.

Patel SJ, Kuten SA, Knight RJ, Hong DM, Gaber AO.

J Transplant. 2014;2014:342319. doi: 10.1155/2014/342319. Epub 2014 Jun 1.

Supplemental Content

Loading ...
Support Center